Cargando…
Multiple drugs: Long-term persistence of the SARS-CoV-2 virus; lack of efficacy: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023724/ http://dx.doi.org/10.1007/s40278-022-13829-z |
Ejemplares similares
-
Long term persistence of SARS-CoV-2 humoral response in multiple sclerosis subjects
por: Maniscalco, Giorgia Teresa, et al.
Publicado: (2022) -
Long term persistence of coronavirus SARS-CoV-2 infection
por: Pinho, João Renato Rebello, et al.
Publicado: (2021) -
Long‐term persistence of neutralizing SARS‐CoV‐2 antibodies in pets
por: Decaro, Nicola, et al.
Publicado: (2021) -
Long-term Persistence of Neutralizing Antibodies to SARS-CoV-2 Following Infection
por: Wisnivesky, Juan P., et al.
Publicado: (2021) -
Lack of Susceptibility to SARS-CoV-2 and MERS-CoV in Poultry
por: Suarez, David L., et al.
Publicado: (2020)